Bangladesh Battles Record Measles Outbreak Amid Vaccine Shortages and Political Turmoil

Since March, Bangladesh has been wrestling with a measles disaster that officials say is the worst the country has ever seen – and, according to the U.S. CDC, the biggest in the world right now.

Official figures from the health ministry put the tally at more than 166,000 suspected cases, of which almost 20,000 have been confirmed in a laboratory. The death toll has crept past 999, with a hundred of those deaths verified as measles‑related. Those numbers sound stark, but they hide a deeper story of children left vulnerable because vaccines didn’t reach them when they needed them.

The outbreak didn’t explode out of thin air. In 2024 and 2025 the country’s routine immunisation programme was repeatedly derailed by a wave of political unrest that followed a violent uprising against the then‑prime minister. Procurement rules were altered, vaccine stocks ran thin and a nationwide measles‑rubella campaign scheduled for 2025 was scrapped altogether.

Health Minister Sardar Md. Sakhawat Husain told parliament that the procurement shake‑up caused a genuine shortage of the measles vaccine, and that the postponement of routine campaigns left a generation of infants – especially those under nine months who are too young for the standard shots – exposed to the virus. The World Health Organisation and UNICEF have echoed those concerns, noting that under‑fives made up about 80 % of the early cases.

For families on the ground the crisis feels painfully personal. Nasima Begum, a 35‑year‑old house‑help, recounted how her 13‑month‑old son fell ill with measles, was turned away from four hospitals, and finally spent ten days in a crowded ward before being sent home still feverish. “We missed his vaccine because he was already sick,” she said, adding that when they tried to get the shot later the clinic simply had none left.

Hospitals are stretched to the breaking point. Shaheed Suhrawardy Medical College Hospital in Dhaka, built for 1,350 patients, is now caring for more than 2,350, with only 60 dedicated measles beds – many of which are merely mats on the floor. Dr. Nanda Dulal Saha, acting director there, warned that a shortage of paediatric saline, a simple but vital fluid for measles patients, is making an already dire situation even worse.

Complicating matters, the summer monsoon has also brought a surge in dengue cases – over 45,000 admissions this year alone – pulling doctors and nurses in two directions at once. “Patients are pouring in, and it is very difficult to accommodate everyone,” Dr. Saha said, his voice reflecting the fatigue of long shifts and endless triage.

In response, the government launched an emergency measles‑rubella campaign in April, aiming to reach roughly 18 million children aged six months to under five years. By early September more than 19.7 million doses had been administered, a massive logistical effort but still not enough to close the immunity gap fully.

Experts such as Professor Mahmudur Rahman, a former director of the Institute of Epidemiology, Disease Control and Research, stress that the priority now is two‑fold: seal the vaccine‑supply loopholes and rebuild public confidence. “To my knowledge, Bangladesh has never witnessed so many children dying from measles,” he said, his tone somber. “Closing the immunity gaps, increasing coverage and stepping up awareness are the immediate priorities.”

As the nation watches the outbreak unfold, the hope is that the emergency drive will finally catch up with the children who missed their shots, and that a more stable political climate will let the health system get back to its pre‑crisis rhythm.